Magnevist (gadopentetate dimeglumine), a gadolinium-based contrast agent which is commonly used to improve the visibility of internal structures when patients undergo an MRI has been linked to a serious, life-threatening [...]
Gadolinium Information
Magnevist MRI Scan & Nephrogenic Systemic Fibrosis (NSF) Lawsuit
Risk for Nephrogenic Systemic Fibrosis in Patients with Advanced Kidney Disease
A study was recently conducted to determine the risk of developing Nephrogenic Systemic Fibrosis (NSF) in patients with advanced kidney disease who had undergone an MRI using a Gadolinium based [...]
Dialysis May Prevent Nephrogenic Systemic Fibrosis
The US Food and Drug Administration recently issued an alert to the healthcare community warning of an increased risk of the development of Nephrogenic Systemic Fibrosis in patients with impaired [...]
Treatment Options for Nephrogenic Systemic Fibrosis / Nephrogenic Fibrosing Dermopathy
Nephrogenic systemic fibrosis (NSF) is an extremely rare condition that occurs in some individuals enduring an advanced stage of kidney disease. Also known as nephrogenic fibrosing dermopathy (NFD), the first [...]
The Symptoms and Signs Of Nephrogenic Systemic Fibrosis / Nephrogenic Fibrosing Dermopathy
Nephrogenic systemic fibrosis (NSF), also known as nephrogenic fibrosing dermopathy (NFD), is a rare condition characterized by the tightening and stiffening of the skin on the extremities. The condition is [...]
Nephrogenic Systemic Fibrosis and MRI Contrast Agents
Until recently, it was believed that MRI contrast agents were some of the safest solutions used on humans. Very few side effects and adverse reactions were reported and many of [...]
The Theory Behind How Gadolinium Based Contrast Agents Cause Nephrogenic Systemic Fibrosis
In 2006, reports began to emerging linking the usage of Gadolinium based contrast agents to the development of a rare condition called Nephrogenic Systemic Fibrosis. The condition was first noted [...]
Devastating Condition Called Nephrogenic Systemic Fibrosis Subject Of Alert By The FDA
The US Food and Drug Administration has recently become aware of a number of cases of Nephrogenic Systemic Fibrosis occurring in some individuals with advanced kidney disease and kidney failure. [...]
Nephrogenic Systemic Fibrosis Associated with Agents Containing Gadolinium
Nephrogenic Systemic Fibrosis is a condition that causes the skin on the extremities to become thick and harden, causing debilitation, severe pain, and disfiguring the person that it affects. The [...]
Do Gadolinium Based Contrast Agents Cause Nephrogenic Systemic Fibrosis?
In 2006, a report was released detailing a rare condition affecting a small number of individuals suffering from kidney damage and kidney failure. The condition was called Nephrogenic Systemic Fibrosis [...]
